Becky Penhallow

800 total citations
10 papers, 293 citations indexed

About

Becky Penhallow is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Becky Penhallow has authored 10 papers receiving a total of 293 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 3 papers in Immunology and 2 papers in Molecular Biology. Recurrent topics in Becky Penhallow's work include Immune Cell Function and Interaction (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Cancer Genomics and Diagnostics (2 papers). Becky Penhallow is often cited by papers focused on Immune Cell Function and Interaction (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Cancer Genomics and Diagnostics (2 papers). Becky Penhallow collaborates with scholars based in United States, Germany and Japan. Becky Penhallow's co-authors include Tai-An Lin, Petra Ross‐Macdonald, Liqi He, Ricardo M. Attar, Heshani de Silva, Steven P. Seitz, Charles Tilford, Qi Guo, Judith Wardwell-Swanson and Jay A. Markwalder and has published in prestigious journals such as Blood, Cancer Research and Frontiers in Immunology.

In The Last Decade

Becky Penhallow

10 papers receiving 285 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Becky Penhallow United States	7	125	75	73	61	50	10	293
Niko Schmiedeberg Germany	9	200 1.6×	123 1.6×	25 0.3×	45 0.7×	27 0.5×	11	358
Zhanzhan Feng China	14	273 2.2×	102 1.4×	50 0.7×	61 1.0×	19 0.4×	19	395
Susan M. Turci United States	10	124 1.0×	37 0.5×	133 1.8×	49 0.8×	27 0.5×	16	356
Wade H. Aaron United States	8	178 1.4×	109 1.5×	60 0.8×	20 0.3×	44 0.9×	18	404
Sandra Kümper United Kingdom	6	311 2.5×	88 1.2×	98 1.3×	39 0.6×	30 0.6×	6	388
Anna M. Schmoker United States	10	193 1.5×	64 0.9×	18 0.2×	31 0.5×	17 0.3×	24	287
Romain M. Larive France	11	234 1.9×	88 1.2×	40 0.5×	18 0.3×	33 0.7×	18	324
Chonlarat Wichaidit United States	12	276 2.2×	43 0.6×	70 1.0×	18 0.3×	23 0.5×	15	418
Ashley Jarvis United Kingdom	5	295 2.4×	122 1.6×	64 0.9×	14 0.2×	23 0.5×	6	367
Jonathan W. Haskins United States	6	251 2.0×	142 1.9×	92 1.3×	9 0.1×	22 0.4×	7	405

Countries citing papers authored by Becky Penhallow

Since Specialization

Citations

This map shows the geographic impact of Becky Penhallow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Becky Penhallow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Becky Penhallow more than expected).

Fields of papers citing papers by Becky Penhallow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Becky Penhallow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Becky Penhallow. The network helps show where Becky Penhallow may publish in the future.

Co-authorship network of co-authors of Becky Penhallow

This figure shows the co-authorship network connecting the top 25 collaborators of Becky Penhallow. A scholar is included among the top collaborators of Becky Penhallow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Becky Penhallow. Becky Penhallow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Ménard, Laurence, Paul Fischer, Peter S. Linsley, et al.. (2018). Renal Cell Carcinoma (RCC) Tumors Display Large Expansion of Double Positive (DP) CD4+CD8+ T Cells With Expression of Exhaustion Markers. Frontiers in Immunology. 9. 2728–2728. 32 indexed citations

Ménard, Laurence, Paul Fischer, Deborah Lee, et al.. (2018). Abstract 4687: Double positive (DP) CD4+CD8+ T cells with an exhausted phenotype in renal cell carcinoma (RCC) patients. Cancer Research. 78(13_Supplement). 4687–4687. 1 indexed citations

Masters, Gregg, et al.. (2014). Abstract 5016: Antitumor activity of anti-PD-1 in combination with tyrosine kinase inhibitors in a preclinical renal cell carcinoma model. Cancer Research. 74(19_Supplement). 5016–5016. 4 indexed citations

Schroeder, Gretchen M., Donna Wei, Patrizia Banfi, et al.. (2012). Pyrazole and pyrimidine phenylacylsulfonamides as dual Bcl-2/Bcl-xL antagonists. Bioorganic & Medicinal Chemistry Letters. 22(12). 3951–3956. 18 indexed citations

He, Liqi, Steven P. Seitz, George L. Trainor, et al.. (2012). Modulation of cofilin phosphorylation by inhibition of the Lim family kinases. Bioorganic & Medicinal Chemistry Letters. 22(18). 5995–5998. 15 indexed citations

Purandare, Ashok V., Animesh Pardanani, Marco M. Gottardis, et al.. (2010). Characterization of BMS-911543, a Functionally Selective Small Molecule Inhibitor of JAK2. Blood. 116(21). 4112–4112. 4 indexed citations

Ji, Rui‐Ru, Heshani de Silva, Robert E. Bruccoleri, et al.. (2009). Transcriptional Profiling of the Dose Response: A More Powerful Approach for Characterizing Drug Activities. PLoS Computational Biology. 5(9). e1000512–e1000512. 22 indexed citations

Ross‐Macdonald, Petra, Heshani de Silva, Qi Guo, et al.. (2008). Identification of a nonkinase target mediating cytotoxicity of novel kinase inhibitors. Molecular Cancer Therapeutics. 7(11). 3490–3498. 102 indexed citations

Das, Jagabandhu, Chunjian Liu, Robert V. Moquin, et al.. (2006). Discovery and SAR of 2-amino-5-(thioaryl)thiazoles as potent and selective Itk inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(14). 3706–3712. 64 indexed citations

10.

Das, Jagabandhu, Chunjian Liu, Robert V. Moquin, et al.. (2006). Discovery and SAR of 2-amino-5-[(thiomethyl)aryl]thiazoles as potent and selective Itk inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(9). 2411–2415. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact